IL5 and COVID-19: The selection of IL-5-Tg mouse model for suPAR-Tg control is based on the following considerations: (1) it has high levels of circulating IL-5; (2) it does not have spontaneous proteinuria at baseline; (3) Like suPAR, high levels of IL-5 are often observed in severe COVID-19 patients18.